Central Ma Hospice 191 Pakachoag Street, Auburn, MA, 01501 | |
(508) 755-4500 |
News Archive
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.
While humorists ponder the old saw about the chicken and the egg, researchers at Baylor College of Medicine focus on the egg, which would not exist without the master geneNobox, which they describe in this week's issue of the journal Science.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
› Verified 3 days ago
Name | Central Ma Hospice |
---|---|
Location | 191 Pakachoag Street, Auburn, Massachusetts |
Hospice ID | 221595 |
Category | Freestanding Hospice |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
SSA county code | 170 |
News Archive
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.
While humorists ponder the old saw about the chicken and the egg, researchers at Baylor College of Medicine focus on the egg, which would not exist without the master geneNobox, which they describe in this week's issue of the journal Science.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
› Verified 3 days ago
NPI Number | 1033542436 |
Organization Name | Visiting Nurse Association Of Southern Worcester County Inc. |
Address | 191 Pakachoag St Auburn, Massachusetts, 01501 |
Phone Number | (508)755-4500 |
News Archive
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.
While humorists ponder the old saw about the chicken and the egg, researchers at Baylor College of Medicine focus on the egg, which would not exist without the master geneNobox, which they describe in this week's issue of the journal Science.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
› Verified 3 days ago
NPI Number | 1720347917 |
Organization Name | Central Ma Hospice, Inc. |
Address | 191 Pakachoag St Auburn, Massachusetts, 01501 |
Phone Number | (508)755-4500 |
News Archive
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.
While humorists ponder the old saw about the chicken and the egg, researchers at Baylor College of Medicine focus on the egg, which would not exist without the master geneNobox, which they describe in this week's issue of the journal Science.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
› Verified 3 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 98.0 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 99.3 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 91.5 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 94.7 | 97.3 |
Patients who got timely treatment for shortness of breath | 95.7 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 96.2 | 93.3 |
News Archive
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.
While humorists ponder the old saw about the chicken and the egg, researchers at Baylor College of Medicine focus on the egg, which would not exist without the master geneNobox, which they describe in this week's issue of the journal Science.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
› Verified 3 days ago
Home Health Aides | 2.14 |
Counselors | 0.44 |
Homemakers | 0.3 |
Licensed Practical or Vocational Nurses | 1.03 |
Medical Social Workers | 0.8 |
Physicians | 0.13 |
Registered Nurses | 5.56 |
Other Personnel | 1 |
Total Employees | 11.4 |
---|
News Archive
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.
While humorists ponder the old saw about the chicken and the egg, researchers at Baylor College of Medicine focus on the egg, which would not exist without the master geneNobox, which they describe in this week's issue of the journal Science.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
› Verified 3 days ago
Others | 0.19 |
Total Volunteers | 0.19 |
---|
News Archive
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.
While humorists ponder the old saw about the chicken and the egg, researchers at Baylor College of Medicine focus on the egg, which would not exist without the master geneNobox, which they describe in this week's issue of the journal Science.
An analysis published August 25 in the open-access journal PLoS Neglected Tropical Diseases sheds new light on the toll that neglected tropical diseases (NTDs) take on sub-Saharan Africa (SSA), with an estimated 500 million people suffering from these debilitating and sometimes deadly diseases.
› Verified 3 days ago
Compassus - Greater Western Massachusetts Location: 15 Midstate Drive, Auburn, Massachusetts, 01501 Phone: (508) 755-4500 |
Central Ma Hospice Location: 191 Pakachoag Street, Auburn, Massachusetts, 01501 Phone: (508) 755-4500 |
Maestro Hospice Care, Llc Location: 1 Saint Mark Street, Suite D, Auburn, Massachusetts, 01501 Phone: (508) 755-4500 |